BBVA USA’s Carter's CRI Stock Holding History

BBVA USA’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$469K	Sell	4,829 -1,204	-20%	-$122K	0.03%	343
2021 Q2	$622K	Buy	+6,033	New	+$615K	0.03%	327

Other funds holding CRI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBVA USA's CRI Position: Q3 2021 in Review

BBVA USA reduced its Carter's (CRI) stake by 20% in Q3 2021, selling an estimated $122K and leaving 4,829 shares worth $469K. The position accounts for 0.03% of the portfolio, ranked #343.

BBVA USA first reported a position in CRI in Q2 2021 and has held it in 2 quarters since. The position peaked at $622K in Q2 2021. 287 funds tracked by Wall St. Rank hold CRI as of Q3 2021.

BBVA USA held 4,829 shares of Carter's worth $469K as of Q3 2021.
BBVA USA sold 1,204 Carter's shares in Q3 2021, an estimated $122K.
Carter's made up 0.03% of BBVA USA's portfolio in Q3 2021, its #343 holding.
BBVA USA first reported a position in Carter's in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Carter's position peaked at $622K in Q2 2021.
287 funds tracked by Wall St. Rank held Carter's as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.